InsiderTrades

Form 4 for PFE Pfizer

Accepted 2026-02-27 00:00:00 ET · period of report 2026-02-25 · accession 0001225208-26-002820 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-02-27 2026-02-25 PFE LANKLER DOUGLAS M EVP F - Tax $26.92 -119.0K 280.0K -30% -$3.20M
D 2026-02-27 2026-02-25 PFE LANKLER DOUGLAS M EVP M - OptEx $33.82 +122.9K 282.2K +77% +$4.16M
D 2026-02-27 2026-02-25 PFE LANKLER DOUGLAS M EVP M - OptEx $0.00 -122.9K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-25 F D 116,811 $26.92 163,177 D — — (F3) The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). (F4) Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
2 Common Common Stock 2026-02-25 F D 2,198 $27.09 279,988 D — — (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
3 Common Common Stock 2026-02-25 M A 122,907 $33.82 282,186 D — — (F1) The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
4 Derivative Stock Appreciation Rights 2026-02-25 M D 122,907 $0.00 0 D $33.82 · 2026-02-25 to 2026-02-25 122,907 Common Stock